Results 161 to 167 of about 3,779 (167)

Paediatric option in MRCP examination: a survey into the results of candidates electing to take the paediatrics option in MRCP (UK) Part II

Medical Education, 1977
Summary Five surveys on the performance of candidates in the paediatric option at MRCP(UK) Part II examination show the paediatric candidates to be at a disadvantage in the written part. The paediatric candidate is later in his career to obtain his MRCP (UK), as the mean interval from qualification to success at ...
openaire   +2 more sources

Targeted downregulation of mCRPs (CD46, CD55, and CD59) specifically sensitizes transferrin-receptor (CD71) high expressing malignant cells to complement attack

Molecular Immunology, 2011
M.C. Cinci, S. Mamidi, M. Kirschfink
openaire   +1 more source

Advantages of mCRP over pCRP in diagnosis of autoimmune diseases

, 2014
A. Myint, R. Berghmans
semanticscholar   +1 more source

Multimeric FHR4 immunoconjugates promote efficient activation of CAP on Her2 tumour cells, further controlled by overexpressed mCRPs, limiting MAC formation and CDC

Molecular Immunology, 2017
Jean-Marc Plesseria, Charlène Verschueren, Gilles Iserentant, Jacques H.M. Cohen, Carole Devaux, Xavier Dervillez   +5 more
openaire   +1 more source

Spezifisches „Targeting“ von Tumorzellen: Zielgerichtete Expressionshemmung humaner membranständiger Komplement-regulatoren (mCRP) zur Überwindung der Komplementresistenz von CD71 hoch-exprimierenden Tumorzellen

2015
openaire   +1 more source

J-Fire Multiservice Procedures for the Joint Application of Firepower: FM 90-20, MCRP 3-16.8B, NWP 3-09.2, AFTTP(I) 3-2.6.

1997
openaire   +1 more source

Exclusive patent, know-how and technology license to use, manufacture, sell and sublicense modified-C-reactive protein 'mCRP' and its genetically engineered recombinant analog recombinant modified C reactive protein 'r(m)CRP', as an adjuvant to be used in human and veterinary vaccine preparations.

1998
openaire   +1 more source